{"url_path":"/sec/indp/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1857044/0001493152-26-023362-index.html","accession_number":"0001493152-26-023362","cik":"0001857044","ticker":"INDP","issuer_name":"Indaptus Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1857044/0001493152-26-023362-index.html","primary_entity_key":"0001857044","primary_entity_name":"Indaptus Therapeutics, Inc."},"word_count":108,"has_tables":true,"body_markdown":"**Item\n1. Legal Proceedings**\n\n \n\nFrom\ntime to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation\nis subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business.\n\n \n\nThere\nare currently no pending material legal proceedings, and we are currently not aware of any legal proceedings or claims against us or\nour property that we believe will have any significant effect on our business, financial position or operating results. None of our officers\nor directors is a party against us in any legal proceeding."}